Comerica Bank Neurocrine Biosciences Inc Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Comerica Bank holds 34,841 shares of NBIX stock, worth $4.72 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

34,841

Previous 152,824 77.2%

Holding current value

$4.72 Million

Previous $21 Million 80.94%

% of portfolio

0.02%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$114.58 - $153.15 $13.5 Million - $18.1 Million	-117,983 Reduced 77.2%	34,841 $4.01 Million
Q2 2024 Aug 15, 2024	BUY	$130.86 - $143.19 $2.25 Million - $2.46 Million	17,178 Added 12.66%	152,824 $21 Million
Q1 2024 May 15, 2024	SELL	$130.4 - $143.74 $1.93 Million - $2.12 Million	-14,778 Reduced 9.82%	135,646 $18.7 Million
Q4 2023 Feb 14, 2024	SELL	$106.07 - $132.76 $536,502 - $671,500	-5,058 Reduced 3.25%	150,424 $19.8 Million
Q3 2023 Nov 21, 2023	BUY	$94.02 - $117.1 $12.9 Million - $16.1 Million	137,338 Added 756.93%	155,482 $17.5 Million
Q2 2023 Aug 22, 2023	SELL	$89.53 - $104.87 $6.38 Million - $7.47 Million	-71,268 Reduced 79.71%	18,144 $60,000
Q4 2022 Jan 26, 2023	SELL	$106.72 - $127.06 $2.76 Million - $3.29 Million	-25,890 Reduced 22.45%	89,412 $0
Q3 2022 Oct 28, 2022	SELL	$92.03 - $107.81 $885,236 - $1.04 Million	-9,619 Reduced 7.7%	115,302 $12.7 Million
Q2 2022 Aug 02, 2022	SELL	$75.79 - $100.07 $816,637 - $1.08 Million	-10,775 Reduced 7.94%	124,921 $12 Million
Q1 2022 Apr 27, 2022	SELL	$72.45 - $94.81 $1.67 Million - $2.18 Million	-23,002 Reduced 14.49%	135,696 $12.7 Million
Q4 2021 Feb 18, 2022	BUY	$79.65 - $106.22 $962,092 - $1.28 Million	12,079 Added 8.24%	158,698 $13.5 Million
Q3 2021 Nov 22, 2021	BUY	$86.18 - $99.03 $162,794 - $187,067	1,889 Added 1.31%	146,619 $14.1 Million
Q2 2021 Aug 26, 2021	BUY	$89.43 - $102.27 $2.67 Million - $3.05 Million	29,856 Added 25.99%	144,730 $14.1 Million
Q1 2021 Apr 28, 2021	BUY	$87.57 - $119.4 $6.47 Million - $8.82 Million	73,869 Added 180.15%	114,874 $11.2 Million
Q4 2020 Jan 28, 2021	BUY	$86.91 - $108.33 $1.91 Million - $2.38 Million	21,933 Added 115.0%	41,005 $3.93 Million
Q3 2020 Oct 30, 2020	BUY	$96.16 - $135.15 $403,872 - $567,630	4,200 Added 28.24%	19,072 $1.83 Million
Q2 2020 Jul 31, 2020	SELL	$85.09 - $130.36 $291,603 - $446,743	-3,427 Reduced 18.73%	14,872 $1.81 Million
Q1 2020 May 01, 2020	BUY	$75.11 - $113.76 $1.05 Million - $1.6 Million	14,021 Added 327.75%	18,299 $1.58 Million
Q4 2019 Feb 07, 2020	BUY	$86.8 - $118.57 $29,946 - $40,906	345 Added 8.77%	4,278 $459,000
Q3 2019 Oct 31, 2019	BUY	$83.82 - $101.5 $10,477 - $12,687	125 Added 3.28%	3,933 $354,000
Q2 2019 Aug 02, 2019	SELL	$72.24 - $91.27 $783,659 - $990,096	-10,848 Reduced 74.02%	3,808 $0
Q1 2019 May 02, 2019	BUY	$69.31 - $91.53 $415,998 - $549,363	6,002 Added 69.36%	14,656 $0
Q4 2018 Feb 06, 2019	BUY	$68.32 - $124.36 $379,107 - $690,073	5,549 Added 178.71%	8,654 $736,000
Q3 2018 Nov 01, 2018	SELL	$98.88 - $125.85 $15,721 - $20,010	-159 Reduced 4.87%	3,105 $337,000
Q2 2018 Aug 01, 2018	SELL	$75.3 - $105.99 $1,506 - $2,119	-20 Reduced 0.61%	3,264 $341,000
Q1 2018 May 01, 2018	SELL	$75.88 - $92.43 $3,490 - $4,251	-46 Reduced 1.38%	3,284 $257,000
Q4 2017 Feb 02, 2018	SELL	$58.53 - $77.59 $2,692 - $3,569	-46 Reduced 1.36%	3,330 $295,000
Q3 2017 Nov 06, 2017	BUY	$47.97 - $61.28 $161,946 - $206,881	3,376	3,376 $210,000

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account